Vaidya Sane Ayurved Laboratories Limited — Important, 14-11-2024: General Updates
Madhavbaug has set a new benchmark in diabetes care through a monumental Glucose Tolerance Test (GTT) event across 350+ clinics, testing over 1,153 type 2 diabetes patients simultaneously. This initiative, which far surpasses the previous record of 660 patients set in 2018, highlights Madhavbaug’s leadership in diabetes management and its commitment to innovative healthcare solutions. The live-streamed event showcased successful patient stories and expert insights, emphasizing a holistic approach involving Ayurveda, personalized diet plans, and lifestyle modifications.
Following this milestone, Madhavbaug is launching the "Madhumeh Mukta Bharat" campaign, targeting 10 crore Indians with education on diabetes prevention and management. The campaign includes plans for 400 nationwide workshops and discounted diabetes screenings at all clinics. Dr. Rohit Sane, Managing Director and CEO, expressed pride in the company's achievements and commitment to providing innovative care, stating that the goal is to empower individuals with the knowledge and tools to manage and potentially reverse diabetes. This reinforces Madhavbaug's position as a pioneer in chronic care, blending modern and traditional healing practices.
All announcements from Vaidya Sane Ayurved Laboratories Limited
